Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/1470022/000103883813000123/k123112.htm
SEC Filings
REON Annual Reports
REON Quarterly Reports
REON Corporate News
New Agreement April 2014
Ending Agreement October 2013
New Agreement September 2013
Change in Assets
Event for Officers
Financial Exhibit
New Agreement
Shell Company Change
Unregistered Sales August 2013
Unregistered Sales March 2013
Unregistered Sales February 2013
Bylaw Change
Regulated Disclosure February 2013
Other Events January 2013
Bylaw Change
Financial Exhibit
Regulated Disclosure January 2013
Other Events January 2013
New Agreement
April 2014
Ending Agreement
October 2013
New Agreement
September 2013
Change in Assets
Event for Officers
Financial Exhibit
New Agreement
Shell Company Change
Unregistered Sales
Event for Officers
Financial Exhibit
New Agreement
Shell Company Change
Unregistered Sales
August 2013
Unregistered Sales
March 2013
Unregistered Sales
February 2013
Bylaw Change
Regulated Disclosure
Regulated Disclosure
February 2013
Other Events
January 2013
Bylaw Change
Financial Exhibit
Regulated Disclosure
Financial Exhibit
Regulated Disclosure
January 2013
Other Events
January 2013
Last10K.com | 10-K Annual Report Thu Mar 28 2013
| Document and Entity Information (USD $) | 12 Months Ended | ||
|---|---|---|---|
| Dec. 31, 2012 | Mar. 18, 2013 | Jun. 29, 2012 | |
| Document And Entity Information | |||
| Entity Registrant Name | RESOLUTE ONCOLOGY INC | ||
| Entity Central Index Key | 0001470022 | ||
| Document Type | 10-K | ||
| Document Period End Date | Dec. 31, 2012 | ||
| Amendment Flag | false | ||
| Current Fiscal Year End Date | --12-31 | ||
| Is Entity a Well-known Seasoned Issuer? | No | ||
| Is Entity a Voluntary Filer? | No | ||
| Is Entity's Reporting Status Current? | Yes | ||
| Entity Filer Category | Smaller Reporting Company | ||
| Entity Public Float | $ 0 | ||
| Entity Common Stock, Shares Outstanding | 40,386,000 | ||
| Document Fiscal Period Focus | FY | ||
| Document Fiscal Year Focus | 2012 |
View differences made from one year to another to evaluate Resolute Oncology Inc's financial trajectory
Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Resolute Oncology Inc.
Assess how Resolute Oncology Inc's management team is paid from their Annual Proxy
Resolute Oncology Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2013 10-K Annual Report includes:
- Voting Procedures
- Board Members
- Executive Team
- Salaries, Bonuses, Perks
- Peers / Competitors
Tools
Financial Statements, Disclosures and Schedules
Inside this 10-K Annual Report
Document And Entity Information
Consolidated Balance Sheets
Consolidated Balance Sheets (parenthetical)
Consolidated Statements Of Cash Flows
Consolidated Statements Of Operations
Consolidated Statements Of Shareholders' Deficit
1. Nature Of Operations
10. Income Taxes
10. Income Taxes (details 1)
10. Income Taxes (details 2)
10. Income Taxes (details)
10. Income Taxes (tables)
11. Going Concern
12. Subsequent Events
2. Recent Accounting Pronouncements
3. Significant Accounting Policies
3. Significant Accounting Policies (details)
3. Significant Accounting Policies (policies)
3. Significant Accounting Policies (tables)
4. Advance On Asset Transfer
4. Advance On Asset Transfer (details Narrative)
5. Mineral Property
6. Related Party Payable
6. Related Party Payable (details Narrative)
7. Note Payable
7. Note Payable (details Narrative)
8. Stock Subscription Payable
9. Capital Stock
Material Contracts, Statements, Certifications & more
Resolute Oncology Inc provided additional information to their SEC Filing as exhibits
Exhibit 10.2: Bridge Loan Agreement Dated November 1, 2012
Exhibit 10.3: Promissory Note With Gen Biopharma Inc. Dated December 31, 2012
Exhibit 10.4: Bridge Loan Agreement With Gen Biopharma Inc. Dated December 31, 2012
Exhibit 14.1: Code Of Business Conduct And Ethics
Exhibit 31.1: Certification Pursuant To Section 302 Of The Sarbanes-Oxley Act Of 2002 Of The P
Exhibit 32.1: Certification Pursuant To Section 906 Of The Sarbanes-Oxley Act Of 2002 Of The P
Ticker: REON
CIK: 1470022
Form Type: 10-K Annual Report
Accession Number: 0001038838-13-000123
Submitted to the SEC: Thu Mar 28 2013 12:49:16 PM EST
Accepted by the SEC: Thu Mar 28 2013
Period: Monday, December 31, 2012
Industry: Metal Mining
External Resources:
Stock Quote
Social Media
Bookmark the Permalink: https://last10k.com/sec-filings/reon/0001038838-13-000123.htm
SEC Filing Exhibit
PDF Download
Loading SEC Filing Exhibit...
SEC Filing Financial Summary
Excel Download
Loading SEC Filing Financial Summary...